Status:
ENROLLING_BY_INVITATION
Rheumatology Biorepository
Lead Sponsor:
CorEvitas
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Brief Summary
The Biorepository is a prospective observational cohort study for patients under the care of a licensed physician or qualified physician extender. Target minimum enrollment is approximately 3,000 pati...
Detailed Description
The purpose of the study is to develop a biorepository of biological samples ("Samples") from eligible patients enrolled in the Corrona Rheumatology Registries (each, a "Registry", together the "Regis...
Eligibility Criteria
Inclusion
- A patient must satisfy all of the following criteria to be eligible for enrollment in the Biorepository study .1)Patient is currently participating in a Registry or is eligible to participate and enrolls in a Registry prior to enrollment in the Biorepository study.
- 2)Patient is starting an Eligible Medication\*with no prior exposure to the specific medication being prescribed.
- 3)Patient is able to complete Sample collection within fourteen (14) days prior to receiving thefirst dose of the Eligible Medication.
Exclusion
Key Trial Info
Start Date :
March 10 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2100
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT04899895
Start Date
March 10 2021
End Date
December 1 2100
Last Update
December 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Corrona, LLC
Waltham, Massachusetts, United States, 02451